Chapter 54: Drugs acting on the upper respiratory tract

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/48

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

49 Terms

1
New cards

What are antitussives?

They block the reflex to cough.

2
New cards

What are decongestants?

Decreased the blood flow to the upper respiratory tract and decrease the overproduction of secretions.

3
New cards

What are antihistamines?

These bloc the release or action of histamines that increases secretions and narrows airways.

4
New cards

What is expectorants?

Increase productive cough to clear ariways?

5
New cards

What are mucolytics?

Increase or liquefy respiratory secretions to aid clearing of airways.

6
New cards

What are the two antitussives that we need to know?

Codeine (opioid) and Dextromethorphan (nonopiod)

7
New cards

What are the actions of antitussives?

They act directly on the medullary cough center of the brain to depress the cough reflex.

8
New cards

What are the indications of antitussives?

Control nonproductive cough

9
New cards

What are the contraindications of antitussives?

Patients who need to cough to maintain the airway and head injury or impaired CNS.

10
New cards

What are the cautions of antitussives?

Hypersensitivity or history of narcotic addictions

11
New cards

What are the adverse effects of antitussives?

Drying effect on the mucous membranes and CNS adverse effects and GI upset.

12
New cards

What are the drug to drug interactions with antitussives?

MAOIs

13
New cards

What should you asses when dealing with antitussives?

History, physical exam, allergies, temperature, respiration, adventitious lung sounds.

14
New cards

What are topical nasal decongestants? (phenylephrine)

They decrease the overproduction of secretions by causing vasoconstriction to the upper respiratory tract.

15
New cards

Topical nasal decongestants actions (phenylephrine)

Sympathomimetic, affects sympathetic nervous system to cause vasodilatation, causing less inflammation of the nasal membrane.

16
New cards

Topical nasal decongestants Indications (phenylephrine)

These relieve the discomfort of nasal congestion that accompanies the common cold, sinusitis and allergic rhinitis.

17
New cards

Topical nasal decongestants Pharmacokinetics (phenylephrine)

This is generally not absorbed systemically and any potion of these topical decongestants that is absorbed is metabolized and excreted normally.

18
New cards

Topical nasal decongestants contraindications (phenylephrine)

Lesions or erosion in the mucous membranes.

19
New cards

Topical nasal decongestants cautions (phenylephrine)

Any conditions that might be exacerbated by sympathetic activity.

20
New cards

Topical nasal decongestants adverse effects (phenylephrine)

Local stinging and burning, rebound congestion and sympathomimetic effects.

21
New cards

Oral decongestants (pseudophedrine)

These decrease nasal congestion related to the common cold, sinusitis and allergic rhinitis.

22
New cards

Oral decongestants (pseudophedrine) Actions

Shrink the nasal mucous membrane by stimulating the alpha-adrenergic receptors in the nasal mucous membranes.

23
New cards

Oral decongestants (pseudophedrine) Indications

Promotion of drainage in the sinuses and improving air flow.

24
New cards

Oral decongestants (pseudophedrine) contraindications

Any condition that might be exacerbated by sympathetic activity.

25
New cards

Oral decongestants (pseudophedrine) adverse effects

There is no rebound congestion and there is sympathetic effects

26
New cards

Oral decongestants (pseudophedrine) Drug to drug interactions

OTC products that contain pseudoephedrine; taking concurrently can cause serious side effects.

27
New cards

Topical nasal steroid decongestants (fluticasone) actions

Relieves inflammation and exact mechanism of action is not know.

28
New cards

Topical nasal steroid decongestants (fluticasone) indications

Seasonal allergic rhinitis and inflammation after the removal of nasal plyps

29
New cards

Topical nasal steroid decongestants (fluticasone) pharmacokinetics

Generally not absorbed systemically

30
New cards

Topical nasal steroid decongestants (fluticasone) Contraindiation

Acute infection.

31
New cards

Topical nasal steroid decongestants (fluticasone) pharmacokinetics

Generally not absorbed systemically

32
New cards

Topical nasal steroid decongestants (fluticasone) cautions

Active infection and avoid exposure to airborne infections

33
New cards

Topical nasal steroid decongestants (fluticasone) adverse effects

Local burning, irritation, stinging, dryness of the mucosa, headache, suppression of healing (if patient has had nasal surgery or trauma)

34
New cards

Antihistamines (dihenhydramine)

These relieve respiratory symptoms and treat allergies.

35
New cards

Antihistamines (dihenhydramine) actions

Selectively block the effects of histamine at the histamine receptor site, which decrease allergic response. These are both anticholinergic and antipruritic.

36
New cards

Antihistamines (dihenhydramine) Indications

Seasonal and perennial allergic rhinitis, allergic conjunctivitis, uncomplicated urticaria and angioedema.

37
New cards

Antihistamines (dihenhydramine) cautions

Renal/Hepatic impairment and history of arrhythmias.

38
New cards

Antihistamines (dihenhydramine) adverse effects

Drowsiness and sedation, anticholinergic effects

39
New cards

Antihistamines (dihenhydramine) drug to drug interactions

These can vary based on the drug

40
New cards

Expectorants (Guaifenesin)

These increase productive cough to clear the airways. They liquefy lower respiratory tract secretions, reducing the viscosity of the secretions and make it easier for the patient to cough.

41
New cards

Expectorants (Guaifenesin) actions

Enhances the output of respiratory tract fluids by reducing the adhesiveness and surface tension of the fluids. Allowing easier movements of the less viscous secretions.

42
New cards

Expectorants (Guaifenesin) Indications

Symptomatic relief of respiratory conditions characterized by dry, non-productive cough.

43
New cards

Expectorants (Guaifenesin) adverse effected

GI symptoms, headache, dizziness, mild rash. A prolonged use may result in masking a serious underlying disorder.

44
New cards

Mucolytics (acetylcysteine)

Increase or liquefy respiratory secretion to aid the clearing of airways in high-risk respiratory patients who are coughing up thick, tenacious secretions.

45
New cards

Mucolytics (acetylcysteine) actions

Work to break down mucous in order to aid the high-risk respiratory patient in coughing up tick, tenacious secretions

46
New cards

Mucolytics (acetylcysteine) Indications

Patient who have difficulty cough up secretions, developed atelectasis, undergoing diagnostic bronchoscopy, Post op patients and patients with trachs.

47
New cards

Mucolytics (acetylcysteine) Pharmacokinetics

Via nebulization or direct instillation into trachea.

48
New cards

Mucolytics (acetylcysteine) causations

Acute bronchospasm, peptic ulcer and esophageal varicies.

49
New cards

Mucolytics (acetylcysteine) Adverse effects

GI upset, stomatitis or rhinorrhea, bronchospasm and rash.